Condition (MeSH)
Laryngitis
ClinicalTrials.gov lists 29 trials for Laryngitis or a narrower condition beneath it. ResApp Health Limited has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
12 of the 29 trials are tagged with Laryngitis itself; the rest are tagged with a narrower condition beneath it.
When did Laryngitis trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 6 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 3 |
| 2014 | 3 |
| 2013 | 1 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Laryngitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 7 |
| Phase 4 | 5 |
| Not applicable | 8 |
| Observational | 8 |
How many Laryngitis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 17 |
| Terminated | 5 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Laryngitis trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| ResApp Health Limited | 3 |
| AstraZeneca | 1 |
| Bitop AG | 1 |
| Canadian Institutes of Health Research (CIHR) | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Laryngitis? (6)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| E3810 | 1 |
| Omeprazole 20 mg | 1 |
| Olive Oil | 1 |
| PREDNISOLONE | 1 |
| OPN-375 | 1 |
Showing 5 of 6 drugs.
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Dexamethasone/Dexamethasone acetate | 5 |
| Dexamethasone IV for PO | 1 |
| Low-dose epinephrine | 1 |
| intramuscular dexamethasone | 1 |
| J022X ST | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Laryngitis? (34)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| HIGH-FLOW NASAL CANNULA POST-TRACHEAL EXTUBATION IN A CHILD WITH UPPER AIRWAY OBSTRUCTION: CASE REPORT. | Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo | 2018 | Yes |
| Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children. | Acta paediatrica (Oslo, Norway : 1992) | 2016 | Yes |
| Hoarseness-causes and treatments. | Deutsches Arzteblatt international | 2015 | Yes |
| Extraesophageal presentations of GERD: where is the science? | Gastroenterology clinics of North America | 2014 | Yes |
| Laryngitis. | BMJ (Clinical research ed.) | 2014 | Yes |
Showing 5 of 34 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.